On March 3, 2023, Aptevo Therapeutics Inc. appointed Jeffrey G. Lamothe, formerly the Company's Executive Vice President, Chief Financial Officer, to Executive Vice President, Chief Operating Officer.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.755 USD | +6.93% | 0.00% | -91.13% |
Apr. 11 | US Equity Markets Close Mixed After March Producer Price Inflation Data | MT |
Apr. 11 | Top Midday Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-91.13% | 1.13M | |
-2.37% | 103B | |
+1.78% | 95.28B | |
+1.46% | 22.15B | |
-15.66% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.91% | 16.05B | |
+5.34% | 13.68B | |
+35.67% | 12.17B |
- Stock Market
- Equities
- APVO Stock
- News Aptevo Therapeutics Inc.
- Aptevo Therapeutics Inc. Appoints Jeffrey G. Lamothe to Executive Vice President, Chief Operating Officer